Remote Monitored Systems continues trials for products

Remote Monitored Systems PLC said Tuesday that its wholly owned subsidiary Pharm 2 Farm Ltd. is continuing trials for two products, and that it is in discussions with potential partners for each product.

The London-listed technology company said that progress on these products has been delayed because of the development of–and focus on–an antiviral mask, and that this has absorbed a significant amount of time.

Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).

There does not appear to be a profile here yet (if this your your plc please get in touch)
Facebook
Twitter
LinkedIn
DirectorsTalk

More articles like this

i(x) Net Zero plc

Impact Investing: Moving towards systemic change

Just a few decades ago, impact investing existed mainly on the fringes. Now it’s a global market estimated at $30.3 trillion, and it isn’t unusual for investors to want to buy shares of companies that are

Quadrise plc

Quadrise open offer oversubscribed, raises £1.0 million

Quadrise said open offer oversubscribed for total of 112.4 million new shares compared to the 82.2 million available. As a result, says a scaling back exercise has become effective, with all applications being met and excess

Ilika plc

Ilika Stereax licensing model overview

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Norcros Plc

Norcros Plc: Market positioning driving growth

FY24 trading underpins Norcros’s compelling investment case, where its new product development initiatives, market positioning and self-help initiatives allow it to take market share in both the UK and South Africa. Edison believe that Norcros’s key

Enteq Technologies plc

Enteq Technologies expects revenue of $900k for 2024

Enteq Technologies expects to report revenue of about $900,000 for the financial year ended 2024, down from $6.2 million posted for financial 2023. The company says this reflects its sale of the XXT business for about

Tern plc

FundamentalVR wins BOLD Awards for EdTech and Metaverse innovations

FundamentalVR, a global leader in immersive surgical training, is proud to announce that it has been awarded two BOLD Awards for ‘Boldest EdTech’ and ‘Boldest Metaverse.’ These distinguished accolades honor FundamentalVR’s commitment to innovate surgical training methods globally,